Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2000
05/16/2000US6063596 G-protein coupled receptors associated with immune response
05/16/2000US6063380 Enhanced immunogenic vaccine
05/16/2000US6063379 Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies
05/16/2000US6063376 Human deoxycytidine kinase 2
05/16/2000CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists
05/16/2000CA2180263C Diazabicyclic neurokinin antagonists
05/16/2000CA2170255C Pharmaceutical composition for immunoenhancement therapy
05/16/2000CA2097820C Proteoglycan(g009) effective in enhancing antitumor immunity
05/16/2000CA2065286C Treatment of chronic inflammatory conditions
05/16/2000CA1340994C Treatment of conditions and disease
05/13/2000CA2289329A1 A suppressive agent against expression of cell adhesion molecules
05/11/2000WO2000026407A1 Method for determining cancer by determining expression of mage-10
05/11/2000WO2000026397A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS)
05/11/2000WO2000026393A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses
05/11/2000WO2000026347A1 Methods for the production of tcr gamma delta t cells
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000WO2000026209A1 Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026197A1 Novel inhibitors of impdh enzyme
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
05/11/2000WO2000026167A1 Vitamin d analogues
05/11/2000WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody
05/11/2000WO2000025815A1 Novel immunoadjuvants
05/11/2000WO2000025812A2 Method for preparing solid phase conjugate vaccines
05/11/2000WO2000025810A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment
05/11/2000WO2000025808A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025780A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025758A1 Oral administration of adenosine analogs
05/11/2000WO2000025746A2 A process for the preparation of suspensions of drug particles for inhalation delivery
05/11/2000WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
05/11/2000WO2000009150A3 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use
05/11/2000WO2000008158A3 Molecules designated ldcam
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000WO1999053036A3 Ste20-related protein kinases
05/11/2000DE19851675A1 Menschliche Interleukin-10 Mutantenproteine Human interleukin-10 mutant proteins
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2348756A1 Enhanced vaccines
05/11/2000CA2348736A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2348285A1 Novel immunoadjuvants
05/11/2000CA2348267A1 Novel inhibitors of impdh enzyme
05/11/2000CA2348234A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
05/11/2000CA2348063A1 Method for preparing solid phase conjugate vaccines
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347119A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0998925A1 Medicinal compositions for topical administration containing vitamin d and vitamin k
05/10/2000EP0998916A1 Medicinal compositions for application to mucosa
05/10/2000EP0998576A2 Bovine adenovirus type 3 genome
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
05/10/2000EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life
05/10/2000EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998455A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain
05/10/2000EP0998305A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998299A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
05/10/2000EP0998298A2 Method of an increasing the antigen presenting ability of monocytes
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0998290A1 Use of vitamin d compounds to prevent transplant rejection
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0998272A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
05/10/2000EP0818202A4 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0494224B1 Use of steroid hormones in compositions for inducing t cell lymphokine production
05/10/2000CN1252811A Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics
05/10/2000CN1252807A Neoglycoproteins
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252791A Arylsecochladiene derivatives
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252719A Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 1172